RxAll Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Investors
-
21
RxAll General Information
Description
Developer of a deep learning hyperspectral IoT platform designed for authenticating drugs in real time. The company's platform works through spectrometers and a cloud dataset of spectral signatures of medicines to carry out non-destructive product authentication, enabling pharma manufacturers to get information in real time about counterfeiting of their products and making high-quality medicines accessible to everyone at affordable prices.
Contact Information
Website
www.rxall.netCorporate Office
- 165 Whitney Avenue
- New Haven, CT 06511
- United States
Corporate Office
- 165 Whitney Avenue
- New Haven, CT 06511
- United States
RxAll Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Later Stage VC | 01-Sep-2026 | Completed | Generating Revenue | |||
| 14. Accelerator/Incubator | 30-Apr-2025 | Completed | Generating Revenue | |||
| 13. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 12. Seed Round | 25-Oct-2021 | Completed | Generating Revenue | |||
| 11. Seed Round | 02-Jun-2021 | Completed | Generating Revenue | |||
| 10. Seed Round | 10-Nov-2020 | Completed | Generating Revenue | |||
| 9. Seed Round | 21-Sep-2020 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 01-Jan-2020 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 16-Oct-2019 | $1.1M | Completed | Generating Revenue | ||
| 6. Grant | 28-Mar-2019 | $113K | $1.1M | Completed | Generating Revenue |
RxAll Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Series A-2 Seed | ||||||||
| Seed-5 | ||||||||
| Seed-4 | ||||||||
| Seed-3 | 1,877,035 | $0.000100 | $0.48 | $0.48 | 1x | $0.48 | 8.67% | |
| Seed-2 | 444,016 | $0.000100 | $0.32 | $0.32 | 1x | $0.32 | 2.05% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
RxAll Signals
RxAll Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FIVE35 Ventures | Venture Capital | Minority | ||
| Investing in Innovation | Accelerator/Incubator | |||
| Harvard Innovation Launch Lab | Accelerator/Incubator | |||
| Fondation Botnar | Not-For-Profit Venture Capital | Minority | ||
| LoftyInc Capital Management | Venture Capital | Minority |
RxAll FAQs
-
When was RxAll founded?
RxAll was founded in 2016.
-
Where is RxAll headquartered?
RxAll is headquartered in New Haven, CT.
-
What is the size of RxAll?
RxAll has 20 total employees.
-
What industry is RxAll in?
RxAll’s primary industry is Enterprise Systems (Healthcare).
-
Is RxAll a private or public company?
RxAll is a Private company.
-
What is RxAll’s current revenue?
The current revenue for RxAll is .
-
How much funding has RxAll raised over time?
RxAll has raised $5.8M.
-
Who are RxAll’s investors?
FIVE35 Ventures, Investing in Innovation, Harvard Innovation Launch Lab, Fondation Botnar, and LoftyInc Capital Management are 5 of 21 investors who have invested in RxAll.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process